HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wouter L J Hinrichs Selected Research

Powders

12/2018Passive inhalation of dry powder influenza vaccine formulations completely protects chickens against H5N1 lethal viral challenge.
11/2018Pulmonary delivery of influenza vaccine formulations in cotton rats: site of deposition plays a minor role in the protective efficacy against clinical isolate of H1N1pdm virus.
10/2018Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge.
6/2015Comparison of adjuvants for a spray freeze-dried whole inactivated virus influenza vaccine for pulmonary administration.
1/2014Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine.
3/2013Development of a dry, stable and inhalable acyl-homoserine-lactone-acylase powder formulation for the treatment of pulmonary Pseudomonas aeruginosa infections.
6/2010Preservation of the immunogenicity of dry-powder influenza H5N1 whole inactivated virus vaccine at elevated storage temperatures.
1/2009Formulation and process development of (recombinant human) deoxyribonuclease I as a powder for inhalation.
9/2007Inulin sugar glasses preserve the structural integrity and biological activity of influenza virosomes during freeze-drying and storage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wouter L J Hinrichs Research Topics

Disease

18Human Influenza (Influenza)
02/2021 - 01/2007
4Infections
02/2021 - 03/2013
2Inflammation (Inflammations)
11/2019 - 11/2017
1Colonic Neoplasms (Colon Cancer)
05/2021
1Pulmonary Fibrosis (Fibrosing Alveolitis)
03/2021
1Fibrosis (Cirrhosis)
03/2021
1Candidiasis (Moniliasis)
03/2021
1Candidemia
03/2021
1Virus Diseases (Viral Diseases)
01/2021
1Bacterial Infections (Bacterial Infection)
01/2020
1Crohn Disease (Crohn's Disease)
05/2016
1Respiratory Tract Infections (Respiratory Tract Infection)
06/2015
1Prostatic Neoplasms (Prostate Cancer)
02/2014
1Weight Loss (Weight Reduction)
01/2014
1Needlestick Injuries (Needlestick Injury)
10/2013
1Pseudomonas Infections
03/2013
1Hemorrhage
02/2013
1Cystic Fibrosis (Mucoviscidosis)
01/2009

Drug/Important Bio-Agent (IBA)

11VaccinesIBA
02/2021 - 09/2007
9PowdersIBA
12/2018 - 09/2007
7Influenza Vaccines (Influenza Vaccine)FDA Link
12/2018 - 06/2010
6InulinFDA Link
01/2015 - 01/2007
4Subunit VaccinesIBA
11/2019 - 06/2010
2Biocompatible Materials (Biomaterials)IBA
03/2021 - 01/2020
2Antiviral Agents (Antivirals)IBA
02/2021 - 01/2021
2Pharmaceutical PreparationsIBA
01/2021 - 02/2013
2delta inulinIBA
12/2018 - 10/2018
2Immunoglobulin G (IgG)IBA
06/2015 - 01/2015
2VirosomesIBA
09/2007 - 01/2007
1Celecoxib (Celebrex)FDA Link
05/2021
1Volatile Oils (Essential Oils)IBA
03/2021
1Oseltamivir (Tamiflu)FDA Link
02/2021
1AntioxidantsIBA
11/2019
1Oxygen (Dioxygen)IBA
11/2019
1Hepatitis B Vaccines (Hepatitis B Vaccine)IBA
11/2019
1Fluorescent Dyes (Fluorescent Probes)IBA
11/2019
1Hepatitis B Surface Antigens (HBsAg)FDA Link
11/2019
1Small Interfering RNA (siRNA)IBA
11/2017
1Messenger RNA (mRNA)IBA
11/2017
1CytokinesIBA
11/2017
1Interleukin-6 (Interleukin 6)IBA
11/2017
1SaponinsIBA
07/2017
1AntigensIBA
07/2017
1GPI0100IBA
07/2017
1Monoclonal AntibodiesIBA
05/2016
1Infliximab (Remicade)FDA Link
05/2016
1AntibodiesIBA
06/2015
1Immunoglobulin A (IgA)IBA
01/2015
11,2-dielaidoylphosphatidylethanolamine (Lipofectin)IBA
02/2014
1Lipid NanoparticlesIBA
02/2014
1Liposomes (Liposome)IBA
02/2014
1LipidsIBA
02/2014
1amidaseIBA
03/2013
1Virulence Factors (Pathogenicity Factors)IBA
03/2013
1Acyl-ButyrolactonesIBA
03/2013
1Oxytocin (Pitocin)FDA LinkGeneric
02/2013
1Peptides (Polypeptides)IBA
02/2013
1dornase alfa (Pulmozyme)FDA Link
01/2009
1Excipients (Suspending Agents)IBA
09/2007
1Dosage Forms (Dosage Form)IBA
09/2007
1Biological ProductsIBA
09/2007
1SugarsIBA
09/2007
1OligosaccharidesIBA
01/2007

Therapy/Procedure

1Therapeutics
03/2021
1Prostheses and Implants (Prosthesis)
01/2020
1Intranasal Administration
06/2010